SODIUM PHOSPHATES INJECTION USP SOLUTION

Country: Կանադա

language: անգլերեն

source: Health Canada

active_ingredient:

SODIUM PHOSPHATE MONOBASIC; SODIUM PHOSPHATE DIBASIC

MAH:

SANDOZ CANADA INCORPORATED

ATC_code:

B05XA09

INN:

SODIUM PHOSPHATE

dosage:

276MG; 268MG

pharmaceutical_form:

SOLUTION

composition:

SODIUM PHOSPHATE MONOBASIC 276MG; SODIUM PHOSPHATE DIBASIC 268MG

administration_route:

INTRAVENOUS

units_in_package:

10X10ML

prescription_type:

Ethical

therapeutic_area:

REPLACEMENT PREPARATIONS

leaflet_short:

Active ingredient group (AIG) number: 0208589002; AHFS:

authorization_status:

APPROVED

authorization_date:

2006-07-21